- Home
- CGTX vs PLUR Comparison
CGTX vs PLUR Comparison
Compare CGTX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- PLUR
- Stock Information
- Founded
- CGTX 2007
- PLUR 2001
- Country
- CGTX United States
- PLUR Israel
- Employees
- CGTX N/A
- PLUR N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CGTX Health Care
- PLUR Health Care
- Exchange
- CGTX Nasdaq
- PLUR Nasdaq
- Market Cap
- CGTX 23.1M
- PLUR 33.6M
- IPO Year
- CGTX 2021
- PLUR N/A
- Fundamental
- Price
- CGTX $0.31
- PLUR $6.08
- Analyst Decision
- CGTX Strong Buy
- PLUR
- Analyst Count
- CGTX 5
- PLUR 0
- Target Price
- CGTX $6.13
- PLUR N/A
- AVG Volume (30 Days)
- CGTX 692.0K
- PLUR 31.8K
- Earning Date
- CGTX 05-07-2025
- PLUR 05-20-2025
- Dividend Yield
- CGTX N/A
- PLUR N/A
- EPS Growth
- CGTX N/A
- PLUR N/A
- EPS
- CGTX N/A
- PLUR N/A
- Revenue
- CGTX N/A
- PLUR $678,000.00
- Revenue This Year
- CGTX N/A
- PLUR $472.39
- Revenue Next Year
- CGTX N/A
- PLUR $254.29
- P/E Ratio
- CGTX N/A
- PLUR N/A
- Revenue Growth
- CGTX N/A
- PLUR 89.92
- 52 Week Low
- CGTX $0.31
- PLUR $3.33
- 52 Week High
- CGTX $2.95
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- CGTX 31.37
- PLUR 63.16
- Support Level
- CGTX $0.40
- PLUR $4.72
- Resistance Level
- CGTX $0.47
- PLUR $5.17
- Average True Range (ATR)
- CGTX 0.03
- PLUR 0.55
- MACD
- CGTX -0.01
- PLUR 0.06
- Stochastic Oscillator
- CGTX 2.76
- PLUR 50.92
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.